Areas of striatal grafts which contain neurons that are characteristic of the striatum are called P-zones. We have investigated whether the paucity of P-zones in human xenografts of lateral ganglionic eminence (LGE) tissue in a rat model of Huntington's disease is due (i) to an absence of the appropriate target cells of LGE neurons or (ii) to the persistence of an immature morphology. Striatal tissue from human embryos of varying sizes (21, 24, and 30 mm in crown-to-rump length) was grafted into the ibotenate-lesioned striatum of immunosuppressed rats, which were killed after 15-17 weeks. In most cases, tissue from the LGE and medial ganglionic eminence (MGE) was transplanted together, whereas some rats received grafts of only LGE tissue. Both types of grafts exhibited positive immunostaining for PCNA (proliferating cells), Vimentin (immature astrocytes), and GAP-43 (outgrowing fibers), which indicates that graft maturation is still ongoing up to 4 months after grafting. Graft survival seemed better when MGE was cografted with LGE, suggesting that the MGE may provide trophic support for LGE neurons and can affect the overall survival of human striatal xenografts. However, the extent of P-zone formation was not increased in MIXED, i.e., LGE plus MGE, grafts. r 1997 Academic Press
INTRODUCTION
Transplantation of embryonic striatal tissue to patients suffering from Huntington's disease is currently being discussed as a therapeutic strategy to restore damaged neural circuits (Brundin et al., 1996; Freeman et al., 1995; Peschanski et al., 1995; Shannon & Kordower, 1996) or to protect the endogenous striatum from the ongoing disease process (Levivier et al., 1995) . Before engaging in systematic clinical trials, it is essential to know under which conditions viable transplants, rich in striatal neurons, can reliably be obtained from human embryonic brain tissue. This is particularly pertinent in view of the recently initiated clinical tests of the transplantation technique in patients with Huntington's disease (Kurth et al., 1996) . Only limited data are available on the development of the human striatal primordium and most of the experience regarding parameters which determine striatal graft survival and development comes from rat and porcine striatal grafts. From these studies it is considered that donor tissue taken from the lateral ganglionic eminence (LGE) 2 alone, as opposed to both the medial ganglionic eminences (MGE) and (LGE) combined, yields a higher proportion of striatal-specific graft regions (Deacon et al., 1994b; Olsson et al., 1995; Pakzaban et al., 1993) . The
